13F
中

MBX MBX BIOSCIENCES INC

2026Q1 · CUSIP 55287L101 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
156
Δ holders QoQ
+17
Breadth percentile
Top 18%
Whale holders
84
Δ whales
+14
Inst. holding value
$1.6B
New positions
39
Closed positions
22
Price momentum (1Q)
-21.3%
Put / Call
2/3

Breadth history (34 quarters)

2024Q4: Δ+19 · h=64 2025Q1: Δ+16 · h=80 2025Q2: Δ+9 · h=89 2025Q3: Δ+29 · h=118 2025Q4: Δ+21 · h=139 2026Q1: Δ+17 · h=156 2024Q4: holders=64 2025Q1: holders=80 2025Q2: holders=89 2025Q3: holders=118 2025Q4: holders=139 2026Q1: holders=156 -29 -14.5 +0 +14.5 +29 57111164 24Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 18% — —
2025Q3 Top 10% +45.5% +22.7%
2025Q1 Top 15% +9.6% +110.8%

Options Sentiment

Put holders
2
QoQ: -1
Call holders
3
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-2.17
EPS YoY
-158.2%
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2025-03-31: EPS -0.71 2025-06-30: EPS -0.58 2025-09-30: EPS -0.63 2025-12-31: EPS -0.46 2026-03-31: EPS -0.50 -0.78 -0.39 0.00 2023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)